Neurochemical and behavioral processes in gerontogenesis in conditions of experimental hyperglycemia.

Many researchers are increasingly interested in the relation between diabetes and diabetic encephalopathy. At the moment, there are various experiments where this issue is considered. But despite prolonged studying, it is impossible to investigate this problem to the end. Cognitive deficit in hyperg...

Full description

Bibliographic Details
Main Author: O. Rodynskyi
Other Involved Persons: K. Basysta ; L. Guz
Format: electronic Article
Language:English
Russian
Ukrainian
Physical Description:Online-Ressource
DOI:10.26641/2307-0404.2018.2.133691
QR Code: Show QR Code
LEADER 01912nma a2200301 c 4500
001 DOAJ031709842
003 DE-601
005 20191101072924.0
007 cr uuu---uuuuu
008 180629s2018 000 0 eng d
024 7 |a 10.26641/2307-0404.2018.2.133691  |2 doi 
035 |a (DE-599)DOAJ4a4312c21fa5454bbea217b1042ae2a7 
040 |b ger  |c GBVCP 
041 0 |a eng  |a rus  |a ukr 
100 0 |a O. Rodynskyi 
245 1 0 |a Neurochemical and behavioral processes in gerontogenesis in conditions of experimental hyperglycemia.  |h Elektronische Ressource 
300 |a Online-Ressource 
520 |a Many researchers are increasingly interested in the relation between diabetes and diabetic encephalopathy. At the moment, there are various experiments where this issue is considered. But despite prolonged studying, it is impossible to investigate this problem to the end. Cognitive deficit in hyperglycemia is also connected with aging. In the aging processes as in hyperglycemia the same pathogenetic factors play a role in the aging of the brain. It is also necessary to deeply analyze the neurochemical processes occurring in the brain in diabetes mellitus. The high incidence of complications is caused by tissue metabolism impairment in hyperglycemia. The study of neurochemical bases of brain activity is one of the leading and promising directions in the modern neuropathology. Scientists of different countries are searching for neurospecific damage markers of the brain substance in hyperglycemia. 
700 0 |a K. Basysta 
700 0 |a L. Guz 
773 0 8 |i In  |g  (01.06.2018) 
856 4 0 |u http://dx.doi.org/10.26641/2307-0404.2018.2.133691 
856 4 0 |y DOAJ  |u https://doaj.org/article/4a4312c21fa5454bbea217b1042ae2a7 
856 4 0 |u http://journals.uran.ua/index.php/2307-0404/article/view/133691 
856 4 0 |u https://doaj.org/toc/2307-0404 
912 |a GBV_DOAJ 
951 |a AR 
952 |j 2018  |b 01  |c 06